Apollo Medical Holdings, Inc., an integrated health care delivery and management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. is based in Alhambra, California.
Industry, Sector and Symbol
Industry Management consulting services
Sub-IndustryN/A
SectorMedical
Phone626-282-0288
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$305.93 million
Profitability
Miscellaneous
Employees493
OptionableNot Optionable
Apollo Medical (NASDAQ:AMEH) Frequently Asked Questions
What is Apollo Medical's stock symbol?
Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."
How were Apollo Medical's earnings last quarter?
Apollo Medical Holdings Inc (NASDAQ:AMEH) released its quarterly earnings data on Wednesday, November, 14th. The company reported $0.24 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.15. The company had revenue of $167.28 million for the quarter. View Apollo Medical's Earnings History.
What price target have analysts set for AMEH?
1 analysts have issued twelve-month price targets for Apollo Medical's stock. Their forecasts range from $25.00 to $25.00. On average, they anticipate Apollo Medical's share price to reach $25.00 in the next twelve months. This suggests a possible upside of 22.0% from the stock's current price. View Analyst Price Targets for Apollo Medical.
What is the consensus analysts' recommendation for Apollo Medical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Apollo Medical.
Has Apollo Medical been receiving favorable news coverage?
Headlines about AMEH stock have been trending positive this week, InfoTrie reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Apollo Medical earned a media sentiment score of 2.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the company's share price in the next several days.
Who are some of Apollo Medical's key competitors?
Some companies that are related to Apollo Medical include FTI Consulting (FCN), RMR Group (RMR), ICF International (ICFI), Huron Consulting Group (HURN), NIC (EGOV), Navigant Consulting (NCI), The Hackett Group (HCKT), Blackrock Capital Investment (BKCC), Avalon Globocare (AVCO), Information Services Group (III), Gopher Protocol (GOPH), Wilhelmina International (WHLM), Pharma Bio Serv (PBSV), Lightbridge (LTBR) and China Internet Nationwide Fncl Srvcs (CIFS).
Who are Apollo Medical's key executives?
Apollo Medical's management team includes the folowing people:
- Dr. Kenneth T. Sim M.D., Exec. Chairman
- Dr. Warren Hosseinion, Co-CEO & Director (Age 47)
- Dr. Thomas S. Lam, Co-CEO & Director (Age 70)
- Mr. Eric Chin, Chief Financial Officer
- Mr. Hing Ang, Chief Operating Officer
Who are Apollo Medical's major shareholders?
Apollo Medical's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (1.04%), Geode Capital Management LLC (0.54%), Northern Trust Corp (0.33%), Royce & Associates LP (0.19%), Bank of New York Mellon Corp (0.18%) and Dimensional Fund Advisors LP (0.09%). Company insiders that own Apollo Medical stock include Adrian Vazquez and Warren Hosseinion. View Institutional Ownership Trends for Apollo Medical.
Which institutional investors are selling Apollo Medical stock?
AMEH stock was sold by a variety of institutional investors in the last quarter, including Paloma Partners Management Co, Royce & Associates LP and New York State Common Retirement Fund. Company insiders that have sold Apollo Medical company stock in the last year include Adrian Vazquez and Warren Hosseinion. View Insider Buying and Selling for Apollo Medical.
Which institutional investors are buying Apollo Medical stock?
AMEH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Northern Trust Corp, Bank of New York Mellon Corp, Geode Capital Management LLC, Dimensional Fund Advisors LP and Great West Life Assurance Co. Can. View Insider Buying and Selling for Apollo Medical.
How do I buy shares of Apollo Medical?
Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Apollo Medical's stock price today?
One share of AMEH stock can currently be purchased for approximately $20.49.
How big of a company is Apollo Medical?
Apollo Medical has a market capitalization of $698.40 million and generates $305.93 million in revenue each year. Apollo Medical employs 493 workers across the globe.
What is Apollo Medical's official website?
How can I contact Apollo Medical?
Apollo Medical's mailing address is 1668 S. Garfield Avenue 2nd Floor, Alhambra CA, 91801. The company can be reached via phone at 626-282-0288 or via email at [email protected]
MarketBeat Community Rating for Apollo Medical (NASDAQ AMEH)
MarketBeat's community ratings are surveys of what our community members think about Apollo Medical and other stocks. Vote "Outperform" if you believe AMEH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMEH will underperform the S&P 500 over the long term. You may vote once every thirty days.
